Collegium Pharmaceutical Taps Vikram Karnani as CEO

Dow Jones11-08
 

By Sabela Ojea

 

Collegium Pharmaceutical said it named Vikram Karnani as chief executive, effective Nov. 12.

The specialty pharmaceutical company on Thursday said that Karnani, who will also be joining the board, replaces interim CEO Michael Heffernan.

Heffernan will remain as chairman of the board. He took over the interim CEO job in May to replace former CEO Joe Ciaffoni.

 

Write to Sabela Ojea at sabela.ojea@wsj.com

 

(END) Dow Jones Newswires

November 07, 2024 17:25 ET (22:25 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment